Buy & Sell Nuwellis Inc (NUWE) – Nuwellis Inc Price Today

NUWE stock trades at $1.19, up 3.89% on the day, while showing a mixed technical picture with a bearish overall signal but neutral oscillators. The company, a medical technology firm focused on cardiorenal conditions, reported 2025 revenue of $8 million but a significant net loss of -$18 million, resulting in a -211.86% net income margin. Recent positive developments include a software update for its Aquadex platform, expansion of its pediatric footprint to 47 centers, and the completion of the Rendiatech acquisition in March 2026.

The investment outlook is highly speculative. The opportunity lies in the company's niche medical technology and recent commercial expansion, supported by a 50% analyst buy rating. However, severe risks dominate, including deeply negative profitability metrics (ROE -382.8%), substantial cash burn with a -$4 million net cash flow in 2025, and reliance on financing activities like a $5 million private placement in January 2026 to fund operations.